Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Chemotherapy and Pharmacology|May 9, 2006
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluationGiacomo Allegrini, Antonello Di Paolo, Elisa Cerri, et al.
Annals of Surgical Oncology|December 24, 2005
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancerGianluca Masi, Samanta Cupini, Lorenzo Marcucci, et al.
Scientific Reports|October 28, 2020
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter DeficiencyFrancesco Cacciante, Mariangela Gennaro, Giulia Sagona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancerDylan M Glubb, Elisa Cerri, Alexandra Giese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2018
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic LeukemiaMatthew S Davids, Michael Hallek, William Wierda, et al.
The Lancet. Oncology|May 15, 2016
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 studyStephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
The New England Journal of Medicine|December 8, 2015
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic LeukemiaAndrew W Roberts, Matthew S Davids, John M Pagel, et al.
The Lancet. Oncology|January 17, 2017
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b studyJohn F Seymour, Shuo Ma, Danielle M Brander, et al.
Pageof 2